| Literature DB >> 27818655 |
Federico Baltar1, Daniel Lundin2, Joakim Palovaara2, Itziar Lekunberri3, Thomas Reinthaler4, Gerhard J Herndl5, Jarone Pinhassi2.
Abstract
To decipher the resEntities:
Keywords: CO2 fixation; alkaline phosphatase; functional diversity; mesopelagic; prokaryotic community structure
Year: 2016 PMID: 27818655 PMCID: PMC5073097 DOI: 10.3389/fmicb.2016.01670
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1Locations where upper mesopelagic water was obtained to establish the experiments during the MOCA cruise in 2010.
Mean values of physical, chemical, and biological properties characterizing the waters used for the experiments.
| 1 | 6 | 10/15/2010 | −32.03 | 15.86 | 395 | 10.95 | 35.33 | 61.57 | 1.942 | 0.07 | 32.15 | 0.017 | 13.2 | 51.0 | 0.67 | 0.48 | 0.71 |
| 2 | 16 | 10/25/2010 | −41.08 | 14.66 | 319 | 10.88 | 35.29 | 94.07 | 1.770 | 0.05 | 28.67 | 0.012 | 12.4 | 55.7 | 0.53 | 0.09 | 0.17 |
| 3 | 17 | 10/26/2010 | −41.05 | 17.71 | 510 | 10.53 | 35.34 | 94.20 | 1.744 | 0.03 | 28.78 | 0.013 | 13.0 | 47.6 | 0.25 | 0.15 | 0.61 |
Theta, potential temperature; DOC, dissolved organic carbon; PHP, prokaryotic heterotrophic production measured via leucine incorporation; DIC, dissolved inorganic carbon fixation.
Figure 2Temporal variation in prokaryotic abundance (A–C) and percentage of high nucleic acid content cells (D–F) in Expt. 1 (A,D), Expt. 2 (B,E), and Expt. 3 (C,F). C, control; TS, thiosulfate; AM, ammonium; OM, pyruvate + acetate.
Prokaryotic abundance, bulk, and cell-specific metabolic rates obtained 24 h after starting the experiments and at the end of the experiments.
| 24 | 1 | C | 1.4 | n.d. | 0.6 | 0.9 | 0.4 | 0.004 | 6.1 | 2.8 | n.d. |
| 24 | 1 | TS | 1.6 | n.d. | 0.9 | 0.8 | 0.4 | 0.006 | 4.9 | 2.4 | n.d. |
| 24 | 1 | AM | 1.5 | n.d. | 0.8 | 0.7 | 0.4 | 0.006 | 5.0 | 2.8 | n.d. |
| 24 | 1 | OM | 1.7 | n.d. | 1.7 | 0.5 | 0.9 | 0.010 | 2.8 | 5.1 | n.d. |
| 24 | 2 | C | 1.0 | n.d. | 1.7 | 0.8 | 0.6 | 0.017 | 8.2 | 6.0 | n.d. |
| 24 | 2 | TS | 1.0 | n.d. | 1.1 | 0.8 | 0.5 | 0.010 | 7.6 | 5.3 | n.d. |
| 24 | 2 | AM | 1.1 | n.d. | 0.9 | 0.8 | 0.6 | 0.008 | 7.3 | 5.5 | n.d. |
| 24 | 2 | OM | 0.9 | n.d. | 1.2 | 6.5 | 41.2 | 0.014 | 76.3 | 482.8 | n.d. |
| 24 | 3 | C | 0.6 | n.d. | 0.8 | 1.0 | 0.3 | 0.013 | 17.0 | 5.3 | n.d. |
| 24 | 3 | TS | 0.9 | n.d. | 0.7 | n.d. | n.d. | 0.008 | n.d. | n.d. | n.d. |
| 24 | 3 | AM | 0.8 | n.d. | 0.5 | n.d. | n.d. | 0.006 | n.d. | n.d. | n.d. |
| 24 | 3 | OM | 1.2 | n.d. | 2.5 | n.d. | n.d. | 0.021 | n.d. | n.d. | n.d. |
| 140 | 1 | C | 3.7 | 45.9 | 37.1 | 8.2 | 8.3 | 0.102 | 22.4 | 22.7 | 1.2 |
| 140 | 1 | TS | 3.7 | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. |
| 140 | 1 | AM | 3.6 | 111.1 | 31.8 | 11.3 | 11.6 | 0.089 | 31.7 | 32.4 | 3.5 |
| 140 | 1 | OM | 112.0 | 240.6 | 162.5 | 70.0 | 134.8 | 0.015 | 6.3 | 12.0 | 1.5 |
| 120 | 2 | C | 1.1 | 15.6 | 20.8 | 1.3 | 0.3 | 0.193 | 12.4 | 3.0 | 0.7 |
| 120 | 2 | TS | 1.0 | 13.5 | 11.4 | 1.1 | 0.3 | 0.115 | 11.3 | 2.7 | 1.2 |
| 120 | 2 | AM | 1.2 | 32.9 | 16.2 | 1.4 | 0.9 | 0.134 | 11.3 | 7.7 | 2.0 |
| 120 | 2 | OM | 37.7 | 987.6 | 2033.2 | 112.2 | 239.6 | 0.539 | 29.7 | 63.5 | 0.5 |
| 110 | 3 | C | 0.7 | 9.8 | 33.0 | 1.1 | 1.0 | 0.497 | 16.9 | 14.8 | 0.3 |
| 110 | 3 | TS | 0.7 | 11.4 | 40.4 | 1.4 | 0.7 | 0.565 | 19.9 | 9.2 | 0.3 |
| 110 | 3 | AM | 0.8 | 24.3 | 45.5 | 1.9 | 0.9 | 0.560 | 23.4 | 11.4 | 0.5 |
| 110 | 3 | OM | 12.5 | 185.0 | 1747.8 | 48.1 | 128.7 | 1.400 | 38.5 | 103.1 | 0.1 |
Expt, experiment; Treat, treatment; PA, prokaryotic abundance (x10.
Figure 3Ratio of the bulk metabolic rates obtained in the different treatments divided by the rates obtained in the control 24 h after (A–C) the amendment and at the end (D–F) of Expt. 1 (140 h) (A,D), Expt. 2 (120 h) (B,E), and Expt. 3 (110 h) (C,F). Error bars show the propagated errors for each parameter for the treatment and control. The line x = 1 indicates no stimulation of rates due to specific treatment effects. Treatments within an experiment are separated by hashed horizontal lines. PHP, prokaryotic heterotrophic production; PA, prokaryotic abundance; HNA, abundance of high nucleic acid content cells; LAPase, leucine aminopeptidase; APase, alkaline phosphatase; DIC, dissolved inorganic carbon fixation. TS, thiosulfate; AM, ammonium; OM. pyruvate + acetate.
Figure 4Composition of prokaryotic assemblages in the enrichment cultures down to the genera level. Percentage of the relative abundance at the end of Exp. 1 (A) and 3 (B), in duplicate carboys (a,b). N, natural waters; C, unamended control; TS, thiosulfate; AM, ammonium; OM, pyruvate + acetate. Example: “AM1a” and “AM1b” are duplicate carboys of the ammonium treatment of Expt. 1. Note that some sequences could not be resolved down to the general level, but the deepest resolved taxonomic level was included in this plot (e.g., other Gammaproteobacteria, Thaumarchaeota, SAR11, SAR324, etc.).
Figure 5Bootstrapped jackknifed hierarchical clustering analysis using UPGMA (Unweighted Pair Group Method with Arithmetic mean). Internal nodes colored indicating the level of support (red: 75–100%, yellow: 50–75%, green: 25–50%, blue: <25%). N, natural waters; C, unamended control; TS, thiosulfate; AM, ammonium; OM, pyruvate + acetate.
Number of observed operational taxonomic units (OTUs) and alpha-diversity indexes for the natural waters and at the end of Expt. 1 and 3.
| N1 | 207 | 29.3 | 5.35 | 0.93 |
| C1b | 55 | 7.7 | 2.7 | 0.75 |
| C1a | 57 | 7.9 | 2.76 | 0.75 |
| TS1b | 34 | 5.27 | 2.34 | 0.65 |
| AM1a | 48 | 6.69 | 2.54 | 0.72 |
| AM1b | 37 | 5.75 | 2.85 | 0.75 |
| OM1b | 19 | 3.75 | 3.05 | 0.82 |
| OM1a | 34 | 5.1 | 2.96 | 0.79 |
| N3 | 207 | 29.3 | 5.4 | 0.93 |
| C3a | 156 | 22 | 4.58 | 0.88 |
| C3b | 164 | 23.2 | 5.02 | 0.92 |
| TS3a | 158 | 22.3 | 4.64 | 0.88 |
| TS3b | 198 | 28 | 5.17 | 0.91 |
| AM3b | 130 | 18.4 | 4.04 | 0.81 |
| AM3a | 112 | 15.8 | 3.93 | 0.83 |
| OM3a | 60 | 8.4 | 3.17 | 0.79 |
| OM3b | 36 | 5 | 2 | 0.63 |
C, unamended control; AM, ammonium; OM, acetate + pyruvate; TS, thiosulfate; N, natural original waters. a,b–denote replicate treatments.
Figure 6Proportion (%) of transcripts retrieved at the end of Expt. 2 (120 h) in the different treatments involved in (A) sulfur (sox) and ammonia oxidation, autotrophic DIC fixation and DIC incorporation by assimilatory carboxylases, and in (B) phosphate acquisition, intracellular C:N balance and histidine kinase/sensor proteins. Numbers on the right are the summed relative abundances in counts per million (CPM) in all treatments and control for each gene. C, unamended control; TS, thiosulfate; AM, ammonium; OM, pyruvate + acetate. sox, sulfur oxidation protein Sox; amoA, ammonia monooxygenase AmoA; creC, two-component response regulator CreC; chvG, sensor histidine kinase ChvG; cusS, copper sensory histidine kinase CusS; GAF sensor signal transduction histidine kinase; basS/pmrB, Sensor protein basS/pmrB; barA, sensory histidine kinase BarA (= VarS = GacS); envZ, osmolarity sensory histidine kinase EnvZ; fleS, flagellar sensor histidine kinase FleS; arcB, aerobic respiration control sensor protein ArcB; phoQ, sensor protein PhoQ; cheA, signal transduction histidine kinase CheA; sypF, signal transduction histidine kinase SypF; yfhK, putative sensor-like histidine kinase YfhK; yfhA, putative sensor-like histidine kinase YfhA; cpxA, copper sensory histidine kinase CpxA; kdpD, osmosensitive K+ channel histidine kinase KdpD; baeS, sensory histidine kinase BaeS.